A Physician’s Clinical Diary-Episode 47: A Lonely Flower in the Crevices of the Mind(2)

 120 Days Fighting the Solitary Fibrous Tumour of the Dura

 


[Progression: The Silent War]


The Language of Cells

Surgery often feels like victory.

But true judgment belongs to pathology.

Three days after the brain tumor surgery for Dural Solitary Fibrous Tumour (SFT), Minseo regained consciousness in the intensive care unit. Her pupils responded symmetrically. Her motor strength was intact. Neurological examination revealed no new deficits.

Technically, the operation had been a success.

Emotionally, however, the war had only begun.

When I entered her recovery room, she looked at me with eyes that carried a fragile blend of relief and terror.

“Is it gone?” she asked.

“The tumor has been completely removed,” I said gently. “Now we must confirm exactly what kind of tumor it was.”

Her husband leaned forward anxiously.

“You already know it’s that… SFT thing, right?”

“In medicine,” I replied carefully, “radiology suggests. Pathology confirms.”


📚 Medical Insight

Dural Solitary Fibrous Tumour (SFT) is a rare mesenchymal tumor originating from fibroblastic cells within the dura mater. Definitive diagnosis requires histopathological confirmation and immunohistochemical staining, most importantly CD34 positivity, STAT6 nuclear expression, and mitotic activity assessment.


The Cold Courtroom

The pathology laboratory was quiet—eerily detached from human suffering.

Slices of Minseo’s tumor were fixed in formalin, embedded in paraffin, and stained with hematoxylin and eosin. Under the microscope, the tumor cells formed a pattern pathologists call a “patternless pattern”, interwoven with branching vascular channels known as staghorn vessels.

Later that afternoon, I met Dr. Han, our senior neuropathologist.

He adjusted his glasses and rotated the microscope lens.

“Classic SFT morphology,” he said calmly.

He continued,

“CD34 strongly positive. STAT6 nuclear staining is positive. Mitotic count low. This is WHO Grade I–II spectrum.”

I exhaled slowly.

A low mitotic count meant slower tumor proliferation. A favorable prognostic indicator.

But SFT carries an unpredictable biological personality.

Some remain dormant for decades.

Others return without warning.


Delivering the Verdict

Breaking medical news to families requires a delicate choreography between truth and hope.

Minseo sat upright in her hospital bed, clutching a blanket as if it were an anchor.

Her daughters were not present. She had chosen to hear the results first.

“The diagnosis is confirmed,” I began.

“You have a Dural Solitary Fibrous Tumour (SFT). It is rare but treatable. The tumor has been completely removed. The cellular activity suggests a lower-grade tumor.”

Her shoulders relaxed slightly.

“But…” she whispered.

She understood instinctively.

“But SFT is known for recurrence,” I said honestly. “Sometimes even years later. In rare cases, it can metastasize to lungs or bones.”

Her husband inhaled sharply.

“So the nightmare isn’t over?”

“It becomes a long-term surveillance journey,” I answered.


📚 Medical Insight

Recurrence rates for Solitary Fibrous Tumour of the Dura range from 20–40%, particularly when gross total resection is incomplete. Long-term MRI follow-up is essential because late recurrence is well-documented.


Minseo remained silent for several seconds.

Then she spoke softly.

“So… I will live with a shadow?”

“Yes,” I replied.
“But shadows exist only when there is light.”


Rehabilitation of the Mind and Brain

Postoperative recovery from brain tumor surgery is not solely neurological. It is a psychological reconstruction.

Minseo developed transient cognitive fatigue, a common postoperative phenomenon due to cortical compression recovery and cerebral edema resolution.

During her rehabilitation sessions, she struggled with memory recall exercises.

“I used to catalog thousands of books,” she sighed. “Now I forget simple words.”

I reassured her,

“The brain heals gradually. Neuroplasticity allows surrounding neural networks to compensate.”


📚 Medical Insight

Neuroplasticity refers to the brain’s ability to reorganize neural pathways after injury or compression. Cognitive rehabilitation plays a crucial role following the removal of intracranial tumors such as Dural SFT.


One afternoon, I overheard her speaking to the rehabilitation therapist.

“I’m scared I won’t be the same mother anymore.”

Her voice cracked.

The therapist responded gently,

“Children don’t need perfect mothers. They need present ones.”

I wrote that sentence in my clinical journal that evening.


The Family’s Invisible Trauma

Medical textbooks rarely mention the suffering of caregivers.

Minseo’s husband, Jisoo, visited daily. He asked detailed medical questions—often repeating them as though repetition could build certainty.

One evening, he stopped me in the hallway.

“Doctor… can stress cause tumors?”

“No,” I answered gently. “There is no proven causal relationship between emotional stress and Dural Solitary Fibrous Tumour formation.”

He nodded slowly.

“I kept telling her to rest more. I thought it was my fault.”

Guilt is a silent epidemic among caregivers.

I placed my hand on his shoulder.

“You did exactly what loving husbands do. You stayed.”

He lowered his head.


The Children’s Questions

Two weeks later, Minseo’s daughters visited the hospital.

The younger one clutched a stuffed rabbit. The older one tried to act brave but avoided eye contact with the surgical scar hidden beneath her mother’s hairline.

“Did the doctor remove the monster from your brain?” the younger daughter asked.

Minseo smiled gently.

“Yes. But the doctor says we must keep watching to make sure it doesn’t grow back.”

The older daughter turned to me.

“Will Mom die?”

Children ask questions adults fear to articulate.

“I am doing everything possible to help your mother live a long life,” I answered carefully.

She nodded, absorbing the answer with premature maturity.


The Follow-Up Scan

One month after surgery, Minseo underwent her first postoperative MRI.

Radiology is a peculiar emotional landscape for neurosurgeons. Each pixel can resurrect nightmares.

The scan appeared on my screen.

No residual tumor.

No postoperative hemorrhage.

Minimal edema.

I felt the familiar surge of restrained relief.

When I showed her the images, she stared silently.

“That empty space…” she said.

“Yes,” I replied.
“That is where the tumor once lived.”

She touched her temple thoughtfully.

“It feels strange… knowing something tried to grow inside me without permission.”


📚 Medical Insight

Complete resection of Dural SFT is the most significant predictor of long-term survival. However, lifelong imaging surveillance remains mandatory due to unpredictable recurrence potential.


The Return of Ordinary Moments

Recovery rarely announces itself dramatically.

It arrives disguised as small victories.

Minseo returned home after six weeks.

She sent me an email later that night.

“Doctor, today I cooked dinner for my family for the first time since surgery. The smell of garlic and sesame oil felt like breathing again.”

I reread the message multiple times.

Medical success is rarely measured in survival curves alone.

Sometimes it is measured in cooking oil and family laughter.


The Doctor’s Private Doubt

Physicians are trained to project confidence.

But uncertainty follows us like a second shadow.

Late one night, I reviewed Minseo’s pathology slides again. SFT tumors possess unpredictable molecular behavior despite benign histology.

“What if it returns?” I wondered silently.

Medicine is built upon probability, not certainty.

I closed her file carefully.

Then I wrote in my journal:

“Hope is not the absence of risk. Hope is the courage to coexist with it.”


The Sixty-Day Mark

By postoperative day sixty, Minseo resumed part-time work at the library.

She visited my clinic wearing professional attire rather than patient clothing.

“You look different,” I told her.

“I feel different,” she replied. “Not healthier. Just… more awake.”

She paused thoughtfully.

“Before the tumor, I lived automatically. Now every morning feels borrowed.”


📚 Medical Insight

Patients surviving rare brain tumors such as Dural Solitary Fibrous Tumour frequently experience post-traumatic growth, a psychological transformation characterized by increased appreciation of life and interpersonal relationships.


The Hidden Contract Between Doctor and Patient

During her routine neurological examination, she suddenly asked,

“Doctor… do you ever get tired of fighting death?”

I considered the question carefully.

“Yes,” I answered honestly.

“Then why continue?”

“Because sometimes we win,” I said quietly.

She smiled.

“Then I guess I am your evidence.”


Approaching the 120-Day Horizon

By day ninety, Minseo demonstrated complete neurological recovery. Her cognitive testing scores normalized. Her visual disturbances had disappeared entirely.

The upcoming 120-day follow-up MRI carried symbolic weight. In neurosurgical oncology, early postoperative stability significantly predicts long-term outcomes.

The day before the scan, she messaged me again:

“Tomorrow feels like judgment day.”

I responded:

Comments

Popular posts from this blog

[MHS: Episode 74] Part I: The Genesis of an Invisible Enemy: When the Body’s Silence Speaks

[Medical Human Story - Episode 64] Shadows of the Retroperitoneum: 72 Hours on the Brink of Life and Death_2

[Medical Human Story - Episode 64] Shadows of the Retroperitoneum: 72 Hours on the Brink of Life and Death_3